Epileptic Anticonvulsants Market - Global Industry Analysis, Market Size, Trends And Forecast, 2014 - 2020

Transparency Market Research Reports incorporated a definite business overview and investigation inclines on "Epileptic Anticonvulsants Market". This report likewise incorporates more illumination about fundamental review of the business including definitions, requisitions and worldwide business sector industry structure.

Epilepsy is a chronic disorder resulting in repeated and unprovoked seizures. Epileptic seizures are commonly referred as convulsions. Anticonvulsants are mainly used for the treatment of epileptic seizures. In addition, anticonvulsants are also used in treatment of bipolar disorder and in neuropathic pain management.

Browse Full Report with TOC:

Epilepsy can affect people of any age group. Though brain injury, brain cancer, drug and alcohol misuse and stroke are some of the reasons for epileptic seizures, exact reason for convulsions is not known. Some of the common symptoms occur before convulsions include, visual loss, strange feeling, nausea, numbness in body parts, headache and racing thoughts. Increasing awareness about anticonvulsants available in the market, patent expiration of many patented drugs are some of the major factors that are driving epileptic anticonvulsants market towards growth. While, cost advantage and convenient dosage forms of currently available generic anticonvulsants are restraining the growth of novel therapies in the epileptic anticonvulsants market. On the basis of therapeutic indication for which anticonvulsants are used, epileptic anticonvulsants market is segmented as follows:

  • Epilepsy

  • Fibromyalgia

  • Migraine

  • Neuropathic pain

  • Bipolar disorder

  • Anxiety

Based on type of drugs, epileptic anticonvulsants market is segmented as follows:

  • Barbiturates

  • Aldehydes

  • Benzodiazepines

  • Aromatic allylic alcohols

  • Carboxamides

  • Bromides

  • Carbamates

  • Sulfonamides

  • Fructose derivatives

  • Pyrrolidines

  • Triazines

  • Fatty acids

  • Oxazolidinediones

  • Ureas

  • GABA analogs

  • Propionates

  • Hydantoins

  • Pyrimidinediones

  • Succinimides

  • Valproylamides (amide derivatives of valproate)

  • Others

Currently, North America dominates the global epileptic anticonvulsants market and is followed by Europe. Factors such as highly developed healthcare infrastructure, high healthcare spending, high rate of awareness about epilepsy and related treatments and availability of skilled healthcare professionals to treat epilepsy are driving North American epileptic anticonvulsants market towards growth. Asia-Pacific is a lucrative region for epileptic anticonvulsants.

Some of the factors such as increasing healthcare spending, rapidly improving healthcare infrastructure and increasing government initiatives to offer improved healthcare facilities on the ground of rapidly growing medical tourism industry in this region are likely to fuel the growth of epileptic anticonvulsants market. Asia Pacific countries mainly India and China are expected to show swift growth in the epileptic anticonvulsants market owing to the growth of medical tourism industry in these countries at a faster rate than other counties in the Asia-Pacific region. Apart from India and China, Japan will play a significant role in the Asia Pacific epileptic anticonvulsants market owing to heavy investment and increasing involvement of Japanese government to improve healthcare infrastructure in the country. Latin American countries mainly, Brazil, Mexico and Argentina have growth potential in the epileptic anticonvulsants market.

Factors such as well defined regulatory framework, availability of pharmaceutical manufacturing facilities and supportive economy are likely to result in the growth of epileptic anticonvulsants market in Latin America. While on the other hand, African countries are expected to show low growth rate in epileptic anticonvulsants market owing to poor economy, lack of healthcare facilities and healthcare professionals. Some of the major companies contributing to the global anticonvulsants market are Johnson & Johnson (J&J), Novartis AG, UCB Group, GlaxoSmithKline plc, Pfizer Inc. and Abbott Laboratories.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

  • North America

  • Asia Pacific

  • Europe

  • Rest of the World

This report provides comprehensive analysis of

  • Market growth drivers

  • Factors limiting market growth

  • Current market trends

  • Market structure

  • Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Enquiry before Buying @

About Us

Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.

We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Latest Upcoming Reports:

Follow on LinkedIn:


Transparency Market Research

90 State Street,
Suite 700,
NY - 12207
United States
Tel: +1-518-618-1030

USA - Canada Toll Free 866-552-3453